Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Leonard D’Amico, Angela Shaulov Kask, Byung Ha Lee, Martin A. Cheever et al.
Citations
9 citations
Journal
Journal for ImmunoTherapy of Cancer
Topics
Viral-associated cancers and disorders
Field-Weighted Citation Impact (FWCI)
9.41
article
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Leonard D’Amico, Angela Shaulov Kask, Byung Ha Lee, Martin A. Cheever, Judith C. Kaiser, Li‐Lian Kwok, Kathryn Lurain, Steven P. Fling, Anna K. Wright, Paul Couey, Robert Yarchoan, Thomas S. Uldrick, Ellen Lyda Burnham, Chia-Ching Jackie Wang, Ramya Ramaswami, Irene Ekwede, Manoj Menon, Allysson Angeldekao
article en
9 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal for ImmunoTherapy of CancerVol. 13(2)
Institutions
University of California, San Francisco (US), Harborview Medical Center (US), Fred Hutch Cancer Center (US), National Cancer Institute (US), UCSF Helen Diller Family Comprehensive Cancer Center (US)
Funders
National Institutes of Health, National Cancer Institute